| pubmed-article:15037537 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C2936350 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C0033554 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C0529330 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C0623362 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C0184512 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C1150224 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:15037537 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:15037537 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:15037537 | pubmed:dateCreated | 2004-3-30 | lld:pubmed |
| pubmed-article:15037537 | pubmed:abstractText | Clinical trials have demonstrated that agents that inhibit the angiotensin II pathway confer benefit beyond the reduction of blood pressure alone. However, the molecular mechanism underlying this effect has yet to be investigated. Recently, we have demonstrated enhanced expression of inducible cyclooxygenase (COX) and prostaglandin (PG)E2-dependent synthase (COX-2/mPGES-1) in human symptomatic plaques and provided evidence that it is associated with metalloproteinase (MMP)-induced plaque rupture. Thus, the aim of this study was to characterize the effect of the angiotensin II type 1 (AT1) receptor antagonist irbesartan on the inflammatory infiltration and expression of COX-2/mPGES-1 and MMPs in human carotid plaques. | lld:pubmed |
| pubmed-article:15037537 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15037537 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15037537 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15037537 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15037537 | pubmed:issn | 1524-4539 | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:MuraroRaffael... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:CuccurulloFra... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:MezzettiAndre... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:CipolloneFran... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:FaziaMariaM | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:IezziAnnalisa... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:ZucchelliMirc... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:PiniBarbaraB | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:UcchinoSanteS | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:SpigonardoFra... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:BeiRobertoR | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:CuccurulloChi... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:BucciMarcoM | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:15037537 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:15037537 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:15037537 | pubmed:day | 30 | lld:pubmed |
| pubmed-article:15037537 | pubmed:volume | 109 | lld:pubmed |
| pubmed-article:15037537 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15037537 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15037537 | pubmed:pagination | 1482-8 | lld:pubmed |
| pubmed-article:15037537 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:meshHeading | pubmed-meshheading:15037537... | lld:pubmed |
| pubmed-article:15037537 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15037537 | pubmed:articleTitle | Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. | lld:pubmed |
| pubmed-article:15037537 | pubmed:affiliation | G. d'Annunzio University of Chieti and the G. d'Annunzio University Foundation, Chieti, Italy. | lld:pubmed |
| pubmed-article:15037537 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15037537 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15037537 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
